WO1998013507A1 - Hex ii tumor-specific promoter and uses thereof in cancer therapy - Google Patents
Hex ii tumor-specific promoter and uses thereof in cancer therapy Download PDFInfo
- Publication number
- WO1998013507A1 WO1998013507A1 PCT/CA1997/000691 CA9700691W WO9813507A1 WO 1998013507 A1 WO1998013507 A1 WO 1998013507A1 CA 9700691 W CA9700691 W CA 9700691W WO 9813507 A1 WO9813507 A1 WO 9813507A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- promoter
- gene
- hex
- tumor
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU42927/97A AU4292797A (en) | 1996-09-25 | 1997-09-22 | Hex ii tumor-specific promoter and uses thereof in cancer therapy |
CA002266846A CA2266846A1 (en) | 1996-09-25 | 1997-09-22 | Hex ii tumor-specific promoter and uses thereof in cancer therapy |
EP97918865A EP0954590A1 (en) | 1996-09-25 | 1997-09-22 | Hex ii tumor-specific promoter and uses thereof in cancer therapy |
US09/739,223 US20010011128A1 (en) | 1996-09-25 | 2000-12-19 | Hex II tumor-specific promoter and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2667896P | 1996-09-25 | 1996-09-25 | |
US60/026,678 | 1996-09-25 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US27600599A Continuation | 1996-09-25 | 1999-03-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998013507A1 true WO1998013507A1 (en) | 1998-04-02 |
Family
ID=21833224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA1997/000691 WO1998013507A1 (en) | 1996-09-25 | 1997-09-22 | Hex ii tumor-specific promoter and uses thereof in cancer therapy |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0954590A1 (en) |
AU (1) | AU4292797A (en) |
CA (1) | CA2266846A1 (en) |
WO (1) | WO1998013507A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1130106A1 (en) * | 2000-03-01 | 2001-09-05 | Rijksuniversiteit te Groningen | Non-squamous epithelium-specific transcription |
WO2003102186A1 (en) * | 2002-05-31 | 2003-12-11 | Medinet Co., Ltd. | Dna inducing cancer cell-specific expression and cancer cell-specific expression vector |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997004104A2 (en) * | 1995-07-14 | 1997-02-06 | The Johns Hopkins University | Tumor type ii hexokinase transcription regulatory regions |
-
1997
- 1997-09-22 EP EP97918865A patent/EP0954590A1/en not_active Withdrawn
- 1997-09-22 WO PCT/CA1997/000691 patent/WO1998013507A1/en not_active Application Discontinuation
- 1997-09-22 CA CA002266846A patent/CA2266846A1/en not_active Abandoned
- 1997-09-22 AU AU42927/97A patent/AU4292797A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997004104A2 (en) * | 1995-07-14 | 1997-02-06 | The Johns Hopkins University | Tumor type ii hexokinase transcription regulatory regions |
Non-Patent Citations (5)
Title |
---|
HARRIS J D ET AL: "GENE THERAPY FOR CANCER USING TUMOUR-SPECIFIC PRODRUG ACTIVATION", GENE THERAPY, vol. 1, no. 3, May 1994 (1994-05-01), pages 170 - 175, XP000654731 * |
HUBER B E ET AL: "VIRUS-DIRECTED ENZYME/PRODRUG THERAPY (VDEPT) SELECTIVELY ENGINEERING DRUG SENSITIVITY INTO TUMORS", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 716, 31 May 1994 (1994-05-31), pages 104 - 114, XP000654773 * |
MATHUPALA S. ET AL.: "Glucose catabolism in cancer cells", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 28, 14 July 1995 (1995-07-14), pages 16918 - 16925, XP002017888 * |
OSAWA H. ET AL.: "Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II gene", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 271, no. 29, 19 July 1996 (1996-07-19), pages 17296 - 17303, XP002050907 * |
REMPEL A. ET AL.: "Glucose metabolism in cancer cells: regulation of the Type II hexokinase promoter by glucose and cyclic AMP", FEBS LETTERS, vol. 385, no. 3, 6 May 1996 (1996-05-06), pages 233 - 237, XP002017889 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1130106A1 (en) * | 2000-03-01 | 2001-09-05 | Rijksuniversiteit te Groningen | Non-squamous epithelium-specific transcription |
WO2001071015A2 (en) * | 2000-03-01 | 2001-09-27 | Rijksuniversiteit Groningen | Non-squamous epithelium-specific transcription |
WO2001071015A3 (en) * | 2000-03-01 | 2002-01-31 | Univ Groningen | Non-squamous epithelium-specific transcription |
AU785144B2 (en) * | 2000-03-01 | 2006-10-05 | Synvolux Ip B.V. | Non-squamous epithelium-specific transcription |
WO2003102186A1 (en) * | 2002-05-31 | 2003-12-11 | Medinet Co., Ltd. | Dna inducing cancer cell-specific expression and cancer cell-specific expression vector |
Also Published As
Publication number | Publication date |
---|---|
AU4292797A (en) | 1998-04-17 |
EP0954590A1 (en) | 1999-11-10 |
CA2266846A1 (en) | 1998-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qian et al. | Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase | |
Katabi et al. | Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells | |
Lan et al. | In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma | |
US5880102A (en) | Adenoviral vector system | |
EP1590001B1 (en) | Method for in vivo regulation of cardiac muscle contractility | |
US20020086836A1 (en) | Cftr gene regulator | |
US7871819B2 (en) | Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene | |
Wesseling et al. | Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma | |
US6605274B1 (en) | Method for in vivo regulation of cardiac muscle contractility | |
Brigham et al. | Expression of human growth hormone fusion genes in cultured lung endothelial cells and in the lungs of mice | |
Bout et al. | In vivo transfer and expression of the lacZ gene in the mouse lung | |
EP0954590A1 (en) | Hex ii tumor-specific promoter and uses thereof in cancer therapy | |
Ishino et al. | Adenovirus-mediated gene transfer to keratinocytes–a review | |
EP3990029A1 (en) | Synthetic genes for the treatment of propionic acidemia caused by mutations in propionyl-coa carboxylase alpha | |
EP2048954B1 (en) | An isolated dna fragment of the sparc human promoter and its use | |
Emamian et al. | Non-viral suicide gene therapy: Cytosine deaminase gene directed by VEGF promoter and 5-fluorocytosine as a gene directed enzyme/prodrug system in breast cancer model | |
US20010011128A1 (en) | Hex II tumor-specific promoter and uses thereof | |
Malkki et al. | The human hexokinase II gene promoter: functional characterization and detection of variants among patients with NIDDM | |
WO1994020629A1 (en) | Eukaryotic expression vectors driven by a myosin heavy chain gene promoter | |
CA2188157A1 (en) | Nucleic acid sequences controlling lung cell-specific gene expression | |
KR20230057336A (en) | Application of methioninase gene therapy to malignant tumors | |
Kang et al. | The piggyBac transposon is an integrating non-viral gene transfer vector that enhances the efficiency of GDEPT | |
Li et al. | Transfection of the DAAO gene and subsequent induction of cytotoxic oxidative stress by D-alanine in 9L cells | |
Chung et al. | Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test | |
WO1994021118A1 (en) | Gene-therapy composition and method for treating carcinomas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2266846 Country of ref document: CA Kind code of ref document: A Ref document number: 2266846 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997918865 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref document number: 1998515083 Country of ref document: JP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997918865 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997918865 Country of ref document: EP |